NEW DELHI, 31 DEC 2024: In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an injectable HIV drug. This drug protects people for six months with each shot. Now, the Science journal has View Details

Related News

• Health Ministry turns to other departments to fill CDSCO workforce gap (03-01-2025)

---

• Mankind Pharma and Innovent Biologics partner to commercialise Sintilimab (03-01-2025)

---

• FDA approves ALYFTREK™, once-daily triple-combination therapy for CF (03-01-2025)

---

• MIB drafts Rules for Online Ads, Influencer Marketing (03-01-2025)

---

• ICMR releases draft second edition of NEDL for stakeholders’ suggestions (03-01-2025)

---

• IIT Guwahati Researchers Develop Innovative Injectable Hydrogel for Targeted Breast Cancer Therapy (03-01-2025)

---

• CDSCO plans to up risk-based inspection, monitoring, sampling, enforcement to check spurious drugs (03-01-2025)

---

• Spurious life-saving drugs sourced from abroad for last 1.5 yrs (02-01-2025)

---

• Maha HM announces third-party testing of medicines supplied in state hospitals (02-01-2025)

---

• CDSCO brings clinical trial site addition and change of PI applications online (02-01-2025)

---